Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation

Item

http://www.wikidata.org/entity/Q35953320

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Infectious risks and optimal s ...... treated kidney transplantation

@ast

Infectious risks and optimal s ...... treated kidney transplantation

@en

type

Item

label

Infectious risks and optimal s ...... treated kidney transplantation

@ast

Infectious risks and optimal s ...... treated kidney transplantation

@en

prefLabel

Infectious risks and optimal s ...... treated kidney transplantation

@ast

Infectious risks and optimal s ...... treated kidney transplantation

@en

P1476

Infectious risks and optimal s ...... treated kidney transplantation

@en

P2093

Chung Hee Baek

http://www.w3.org/2001/XMLSchema#string

Duck Jong Han

http://www.w3.org/2001/XMLSchema#string

Jae Berm Park

http://www.w3.org/2001/XMLSchema#string

Kyung Sun Park

http://www.w3.org/2001/XMLSchema#string

Su-Kil Park

http://www.w3.org/2001/XMLSchema#string

Won Seok Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.

Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation

Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.

Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.

Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation.

Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study.

ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.

The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction.

Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.

Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab.

P304

66-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000337339

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225056781

http://www.w3.org/2001/XMLSchema#string

P698

22619669

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

3350352

http://www.w3.org/2001/XMLSchema#string